title: Hyperdynamic myocardial response to beta-adrenergic stimulation in patients with chest pain and normal coronary arteries.
abstract: OBJECTIVE
  The goal of this study was to test the hypothesis that an abnormal response to beta-adrenergic stimulation may play a role in the pathophysiology of chest pain in patients with normal coronary arteries.
  
  
  BACKGROUND
  The mechanism of angina-like (AL) chest pain in patients with angiographically normal coronary arteries remains controversial.
  
  
  METHODS
  Fifty-eight patients with AL pain and a normal coronary angiogram underwent dobutamine echocardiography (DE) to evaluate regional wall motion and intraventricular flow velocities (IFV). Control patients consisted of 22 matched patients free of angina and coronary artery disease. Abnormal IFV were defined as dagger-shaped Doppler spectrum > or =3 m/s.
  
  
  RESULTS
  Dobutamine-induced regional wall motion abnormalities did not develop in any of the patients. An IFV > or = 3 m/s was found in 28 patients (48%) with AL pain but in only 4 (18%) control patients (p < 0.05). In the subgroup of patients with AL pain and IFV > or =3 m/s, plasma renin concentration (PRC) was higher as compared with those with IFV <3 m/s (18 +/- 17 pg/ml vs. 9 +/- 6 pg/ml, p < 0.05). There were no differences in plasma ADR, NADR, or angiotensin-converting enzyme levels. Fourteen patients with angina and IFV > or =3 underwent control DE and blood sampling after 6 weeks treatment with 10 mg of bisoprolol. In these patients, a decrease in IFV (from 3.4 +/- 0.35 m/s to 2.46 +/- 0.64 m/s, p < 0.001) and a decrease in angina score (from 5.4 +/- 1.5 to 0.6 +/- 1.4, p < 0.001) were observed at follow-up.
  
  
  CONCLUSIONS
  The present data suggest that an exaggerated myocardial response to beta-adrenergic stimulation plays a role in the mechanisms of chest pain in some patients with normal coronary arteries.
authors.affiliation: Cardiovascular Centre Aalst, OLV Clinic, Aalst, Belgium.
authors.forename: Juraj
authors.initials: J
authors.lastname: Madaric
authors.forename: Jozef
authors.initials: J
authors.lastname: Bartunek
authors.forename: Katia
authors.initials: K
authors.lastname: Verhamme
authors.forename: Martin
authors.initials: M
authors.lastname: Penicka
authors.forename: Eddy
authors.initials: E
authors.lastname: Van Schuerbeeck
authors.forename: Paul
authors.initials: P
authors.lastname: Nellens
authors.forename: Guy R
authors.initials: GR
authors.lastname: Heyndrickx
authors.forename: William
authors.initials: W
authors.lastname: Wijns
authors.forename: Marc
authors.initials: M
authors.lastname: Vanderheyden
authors.forename: Bernard
authors.initials: B
authors.lastname: De Bruyne
mesh_terms: D000318:Adrenergic beta-Agonists; D000787:Angina Pectoris / Q000503:physiopathology; D002637:Chest Pain / Q000000981:diagnostic imaging* / Q000503:physiopathology*; D025401:Echocardiography, Stress; D005260:Female; D006321:Heart / Q000503:physiopathology; D006439:Hemodynamics; D006801:Humans; D008297:Male; D008875:Middle Aged
chemical_list: D000318:Adrenergic beta-Agonists